G&S Capital’s Boston Scientific BSX Stock Holding History

G&S Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,992	Closed	-$2.54M	–	134
2025 Q3	$2.54M	Buy	25,992 +611	+2%	+$63.3K	0.94%	42
2025 Q2	$2.73M	Buy	25,381 +453	+2%	+$45.8K	1.08%	31
2025 Q1	$2.51M	Sell	24,928 -2,314	-8%	-$233K	1.07%	33
2024 Q4	$2.43M	Buy	27,242 +13,572	+99%	+$1.19M	1%	42
2024 Q3	$1.15M	Buy	+13,670	New	+$1.08M	0.48%	66
2020 Q1	–	Sell	-1,675	Closed	-$75K	–	193
2019 Q4	$75K	Buy	+1,675	New	+$70.1K	0.04%	120
2019 Q1	–	Sell	-400	Closed	-$14K	–	221
2018 Q4	$14K	Buy	+400	New	+$14.5K	0.01%	139

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

G&S Capital's BSX Position: Q4 2025 in Review

G&S Capital sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 25,992 shares — an estimated $2.54M sold.

G&S Capital first reported a position in BSX in Q4 2018 and held it in 7 quarters. The position peaked at $2.73M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

G&S Capital reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
G&S Capital sold 25,992 Boston Scientific shares in Q4 2025, an estimated $2.54M.
G&S Capital first reported a position in Boston Scientific in Q4 2018 and held it in 7 quarters.
G&S Capital's Boston Scientific position peaked at $2.73M in Q2 2025.
1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on G&S Capital's 13F filing for Q4 2025, filed 28 Jan 2026.